Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics
Authors:
- Wojciech MichnoWMWojciech Michno
- Katie M. StringerKSKatie M. Stringer
- Thomas EnzleinTEThomas Enzlein
- Melissa K. PassarelliMPMelissa K. Passarelli
- Stephane EscrigSEStephane Escrig
- Karina VitanovaKVKarina Vitanova
- Jack WoodJWJack Wood
- Kaj BlennowKBKaj Blennow
- Henrik ZetterbergHZHenrik Zetterberg
- Anders MeibomAMAnders Meibom
- Carsten HopfCHCarsten Hopf
- Frances A. EdwardsFEFrances A. Edwards
Open Access
- 18 June 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (25) , eabg4855
Abstract
β-Amyloid (Aβ) plaque formation is the major pathological hallmark of Alzheimer’s disease (AD) and constitutes a potentially critical, early inducer driving AD pathogenesis as it precedes other pathological events and cognitive symptoms by decades. It is therefore critical to understand how Aβ pathology is initiated and where and when distinct Aβ species aggregate. Here, we used metabolic isotope labeling in APPNL-G-F knock-in mice together with mass spectrometry imaging to monitor the earliest seeds of Aβ deposition through ongoing plaque development. This allowed visualizing Aβ aggregation dynamics within single plaques across different brain regions. We show that formation of structurally distinct plaques is associated with differential Aβ peptide deposition. Specifically, Aβ1-42 is forming an initial core structure followed by radial outgrowth and late secretion and deposition of Aβ1-38. These data describe a detailed picture of the earliest events of precipitating amyloid pathology at scales not previously possible.Keywords
All Related Versions
Funding Information
- Cure Alzheimer’s Fund
- Alzheimer’s Research UK (ARUK-PPG2018B-025)
- Vetenskapsrådet (2018-02181)
- Åhlén-stiftelsen (203010)
- Alzheimerfonden (2019-00807)
This publication has 62 references indexed in Scilit:
- Effects of Age and Amyloid Deposition on Aβ Dynamics in the Human Central Nervous SystemArchives of Neurology, 2012
- Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's DiseaseThe American Journal of Pathology, 2011
- In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeksActa Neuropathologica, 2010
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s diseaseActa Neuropathologica, 2010
- Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral AmyloidosesACS Chemical Biology, 2009
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- 15N Metabolic Labeling of Mammalian Tissue with Slow Protein TurnoverJournal of Proteome Research, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991